Merck & Co. has agreed to acquire Verona Pharma for $10 billion, the companies said, in a deal designed to expand the pharma ...

GREmLN leverages a graph-based architecture to represent gene-gene interactions to predict cell behavior for therapeutic ...

Methylation changes in microbiome-derived cfRNA enable more accurate CRC diagnosis than traditional DNA or abundance-based ...

Revolution Medicines' proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand ...

The potential of gene therapies will only be realized if the manufacturing challenges can be resolved, and that’s a tricky ...

Researchers predict that industry adoption of continuous manufacturing will accelerate in response to competitive pressure.

The best way to ensure consistency as bioassays are transferred among labs and scaled up is to plan early on for those ...

Pharmaceutical manufacturers are under immense pressure to streamline their processes, reduce waste, and improve output.

CZI and the IGI announce the funding of the Center for Pediatric CRISPR Cures to use CRISPR-based editing technology to advance cures.

Findings suggest that Alzheimer’s risk genes drive tau buildup and spread through both network-based and independent mechanisms.